Research suggests that glp-1 drugs, such as semaglutide, may have a role in preventing or treating dementia. Some studies have found a link between the use of these medications and a lower risk of dementia in certain patients, including those with type 2 diabetes. The potential of glp-1 drugs to address dementia is being explored, with some organizations investing in further research and considering their use in combination with lifestyle changes.